![Theresa Mansi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Theresa Mansi
Sociétés | Poste | Début | Fin |
---|---|---|---|
NexEos Diagnostics, Inc.
![]() NexEos Diagnostics, Inc. Medical/Nursing ServicesHealth Services NexEos Diagnostics, Inc. operates as a medical diagnostics company focuses on disorders related to white blood cells. The company is headquartered in Wayne, PA. | Directeur/Membre du Conseil | - | - |
Directeur Général | - | - | |
NexEos Bio, Inc.
![]() NexEos Bio, Inc. Medical/Nursing ServicesHealth Services NexEos Bio is a medical diagnostics company that aims to improve the detection, diagnosis, treatment, and management of patients with chronic, eosinophil-related inflammatory diseases. The company is based in Wayne, PA. The company's lead program is a non-invasive imaging agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis (EoE). This program has the potential to improve patients' quality of life, more rapidly diagnose their disease, and may help delay disease progression. The company was founded by Gerald Gleich, and the CEO is Theresa Mansi. | Directeur Général | - | - |
Historique de carrière de Theresa Mansi
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Executive Officer | 2 |
Director/Board Member | 1 |
Sectorielle
Health Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
NexEos Diagnostics, Inc.
![]() NexEos Diagnostics, Inc. Medical/Nursing ServicesHealth Services NexEos Diagnostics, Inc. operates as a medical diagnostics company focuses on disorders related to white blood cells. The company is headquartered in Wayne, PA. | Health Services |
NexEos Bio, Inc.
![]() NexEos Bio, Inc. Medical/Nursing ServicesHealth Services NexEos Bio is a medical diagnostics company that aims to improve the detection, diagnosis, treatment, and management of patients with chronic, eosinophil-related inflammatory diseases. The company is based in Wayne, PA. The company's lead program is a non-invasive imaging agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis (EoE). This program has the potential to improve patients' quality of life, more rapidly diagnose their disease, and may help delay disease progression. The company was founded by Gerald Gleich, and the CEO is Theresa Mansi. | Health Services |
- Bourse
- Insiders
- Theresa Mansi
- Expérience